SCHEMBL10565535

SCHEMBL10565535

COc1ccc(-c2cc(=O)[nH]c(=O)n2C)cc1OC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.52
▸ MAPT P10636 3/20 0.52
▸ ALDH1A1 P00352 2/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ THRB P10828 1/20 0.50
▸ PDE4A P27815 2/20 0.47
▸ PDE4B Q07343 2/20 0.47
▸ PDE4C Q08493 2/20 0.47
▸ PDE4D Q08499 2/20 0.47
▸ PLAT P00750 1/20 0.45
▸ CYP19A1 P11511 1/20 0.43
▸ ADORA2A P29274 1/20 0.43
▸ PDE3B Q13370 2/20 0.42
▸ PDE3A Q14432 2/20 0.42
▸ TDP2 O95551 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ KDM4C Q9H3R0 1/20 0.41
▸ TLR9 Q9NR96 1/20 0.41
▸ TLR7 Q9NYK1 1/20 0.41
▸ MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10568592 0.87 KDM4E (0.46) KDM4EMAPTALDH1A1SMN1; SMN2THRB
SCHEMBL10566820 0.78 MAPT (0.50) KDM4EMAPTALDH1A1SMN1; SMN2THRB
SCHEMBL10566825 0.78 MAPT (0.50) KDM4EMAPTALDH1A1SMN1; SMN2THRB
SCHEMBL10339766 0.77 KDM4E (0.57) KDM4EMAPTALDH1A1SMN1; SMN2THRB
SCHEMBL10568294 0.76 TSHR (0.50) KDM4EMAPTALDH1A1THRBPDE4A
SCHEMBL10565006 0.75 ALDH1A1 (0.55) KDM4EMAPTALDH1A1SMN1; SMN2THRB
SCHEMBL14937013 0.74 MPO (0.65) KDM4EMAPTALDH1A1THRBPDE4A
SCHEMBL14936607 0.74 ALDH1A1 (0.53) KDM4EMAPTALDH1A1THRBGAA
SCHEMBL14937198 0.74 MPO (0.65) KDM4EMAPTALDH1A1THRBPDE4A
SCHEMBL10567603 0.74 KDM4E (0.42) KDM4EMAPTALDH1A1THRBPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4824851-A Pyrimidones as cardiotonic, anti hypertensive, cerebrovascular vasodilator and anti-platelet agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-04-25 — — US disclosed
EP-0123402-B1 PYRIMIDINE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-09-07 — — EP disclosed
US-4746664-A Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-05-24 — — US disclosed
US-4612376-A Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-09-16 — — US disclosed
EP-0123402-A2 Pyrimidine derivatives, preparation thereof and use thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-10-31 — — EP disclosed
Send feedback